national
Johnson & Johnson In Talks to Sell Orthopedics Division to Apollo for $20 Billion
Just the facts
Medical products manufacturer Johnson & Johnson entered preliminary discussions to sell its orthopedics division to private equity firm Apollo Global Management. The business unit manufactures hip and knee replacement implants and surgical devices, with the potential divestiture valued at approximately $20 billion. The negotiations align with Johnson & Johnson's corporate strategy to streamline its medical technology operations and prioritize higher-margin health divisions. If completed, the transaction would rank among the largest private equity acquisitions within the medical technology sector.
Why this is news
Johnson & Johnson entered financial negotiations to sell its orthopedics business to private equity firm Apollo Global Management in a transaction valued at $20 billion.
Sources
This summary is compiled strictly from the original reporting below.